COVID-19

The World Health Organization (WHO) declared the Coronavirus outbreak a pandemic in March 2020, and we are very closely following the changing situation on a daily basis.

We want to support your assay development projects in this difficult time and combined all our COVID-19 related info and SARS CoV-2 related products here:

Our SARS CoV-2 Related Products:

SARS-CoV-2 Spike RBD, mammalian recombinant

SARS-CoV-2 Spike, antibody

IgA antibody
IgG antibody

SARS-CoV-2 Nucleoprotein, recombinant

SARS-CoV-2 Nucleoprotein, antibody

IgM antibody

COVID-19 Related News:

NEW! COVID-19 Antibodies – R&D Samples Available

We are pleased to let you know that we are developing several monoclonal antibodies...
Read more >>

NEW! HyTest Live Webinar - Diagnostics of COVID-19: Achievements, Challenges and Perspectives

Welcome to our next live Webinar!
Sign up now >>

SARS-CoV-2 Antigens TechNotes

New TechNotes including latest data about our COVID-19 antigens. Read more >>

Major Predictors of COVID-19 Severity

You can find many markers in our portfolio that are referred as major predictors of COVID-19 severity. Read more >>

HyTest Operations During Covid-19 Pandemic

We are able to continue our operations during the pandemic but there might be some delays in the deliveries. Read more >>

HyTest Webinar - COVID-19: Biomarkers to Distinguish Severity and Prognosis

Welcome to watch our first Webinar related to COVID-19. Read more and see the webinar >>

HyTest Ltd

Intelligate 6th floor
Joukahaisenkatu 6
20520 Turku, Finland

Tel. +358-2-512-0900
hytest(at)hytest.fi

Youtube

Copyright © 2018 HyTest Ltd.